BioSpace News Archive

Business

Samsung Biologics Reports Second Quarter 2022 Financial Results

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the second quarter of fiscal year 2022.

July 27, 2022
·
4 min read
Pharm Country

Dr. Reddy’s Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market

Dr. Reddy’s Laboratories Ltd. announced the launch of Bortezomib for Injection 3.5 mg, the generic equivalent of Velcade® Injection, in the U.S. market approved by the U.S. Food and Drug Administration.

July 27, 2022
·
3 min read
Deals

Italfarmaco Acquires 100% of Lacer, a Spanish Pharmaceutical Company That Is a Leader in Health Care and Personal Hygiene

Italfarmaco, an Italian multinational company in the chemical-pharmaceutical sector, has acquired 100% of Lacer Pharmaceuticals, one of the leading companies in Spain in the area of health and personal hygiene.

July 27, 2022
·
4 min read
Business

Boston Scientific Announces Results for Second Quarter 2022

Boston Scientific Corporation generated net sales of $3.244 billion during the second quarter of 2022, growing 5.4 percent on a reported basis, 9.6 percent on an operational1 basis and 6.6 percent on an organic2 basis, all compared to the prior year period.

July 27, 2022
·
24 min read
Biotech Bay

Reviva Pharmaceuticals Provides Update on Clinical Development Pipeline

Reviva Pharmaceuticals Holdings is pleased to provide an update on key milestones related to its clinical development pipeline.

July 27, 2022
·
8 min read
Business

Atlantic Therapeutics Announces the Appointment of Russell Medford MD, PhD as New US-Based Chairman

Today Atlantic Therapeutics, a Galway, Ireland and Boston, USA-based MedTech innovator, announces the appointment of Russell Medford MD, PhD as Chairman.

July 27, 2022
·
4 min read
Drug Development

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

Ortho Regenerative Technologies Inc. today announced the initiation of patients’ enrollment following completion of the first patient surgery in its U.S. Phase I/II rotator cuff tear repair clinical trial.

July 27, 2022
·
3 min read
ZyVersa Therapeutics and University of Miami Awarded a Grant from The Michael J. Fox Foundation

ZyVersa Therapeutics, Inc. (ZyVersa), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is honored to receive a grant from The Michael J. Fox Foundation for Parkinson’s Research.

July 27, 2022
·
4 min read
Business

Ionis to hold second quarter 2022 financial results webcast

Webcast scheduled for Tuesday, August 9 at 11:30 a.m. Eastern Time.

July 27, 2022
·
1 min read
Business

Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies

AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs.

July 27, 2022
·
6 min read